In the age of technology, Diabeta appears as an innovative medical chatbot, providing essential information to healthcare professionals. The platform is based on data from Summaries of Product Characteristics (SmPCs), official guidelines and protocols, consolidating itself as a reference tool for diabetologists.
REAL-TIME EFFICIENCY FOR DIABETOLOGISTS
Diabeta becomes the reliable partner for diabetologists, providing prompt and quick answers to questions about treatment, measures and principles in applying treatments. Through advanced processing of medical documents, including drug SmPCs, Diabeta ensures that the information provided is up-to-date and relevant.
TANGIBLE BENEFITS FOR HEALTHCARE PROFESSIONALS
Diabeta is not just a chatbot, it is an essential tool for diabetologists. Through quick access to quality information from official sources, the platform eliminates uncertainty about available treatments. The natural interaction, supported by voice functions, not only improves communication, but also strengthens doctors’ confidence in the information provided by Diabeta.
Developed by the Romanian company Apollo Technologies, DIABETA benefits from the support of prestigious partners such as Novo Nordisk, Boehringer Ingelheim and Medtronic. This partnership shows how a local initiative can have a global impact, bringing together resources and experiences to tackle diabetes challenges.